Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$7.82 USD
-0.26 (-3.22%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.81 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Earnings News For IRWD
-
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
-
Ironwood: Q4 Earnings Snapshot
-
Ironwood: Q4 Earnings Snapshot
-
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
-
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
-
Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises
-
Ironwood: Q3 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
-
Why Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report?
-
Ironwood Pharmaceuticals (IRWD) Q2 Earnings and Revenues Surpass Estimates
-
Ironwood: Q2 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS? U.S. Net Sales and Ironwood Revenue Guidance
-
Ironwood (IRWD) Q1 Earnings Beat Estimates, Linzess Volume Up
-
Ironwood Pharmaceuticals (IRWD) Surpasses Q1 Earnings and Revenue Estimates
-
Ironwood: Q1 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance
-
Ironwood (IRWD) Q4 Earnings Miss, Linzess Volume Increases
-
Ironwood Pharmaceuticals (IRWD) Misses Q4 Earnings and Revenue Estimates
-
Ironwood: Q4 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results
-
Ironwood Pharmaceuticals (IRWD) Earnings Expected to Grow: Should You Buy?
-
Ironwood's (IRWD) Q3 Earnings Beat, Linzess Volume Grows
-
Ironwood Pharmaceuticals (IRWD) Beats Q3 Earnings Estimates
-
Ironwood: Q3 Earnings Snapshot
-
Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance